| Literature DB >> 30138318 |
Wilbroad Mutale1, Samuel Bosomprah2,3, Perfect Shankalala1, Oliver Mweemba1, Roma Chilengi2, Sharon Kapambwe4, Charles Chishimba4, Mulenga Mukanu1, Daniel Chibutu1, Douglas Heimburger5.
Abstract
INTRODUCTION: Sub-Saharan Africa is experiencing an epidemiological transition as the burden of NCDs overtake communicable diseases. However, it is unknown what capacity and gaps exist at primary care level to address the growing burden of NCDs. This study aimed to assess the Zambian health system's capacity to address in NCDs, using an adapted WHO Essential Non Communicable Disease Interventions (WHO PEN) tool.Entities:
Mesh:
Year: 2018 PMID: 30138318 PMCID: PMC6107121 DOI: 10.1371/journal.pone.0200994
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of health facilities.
| Characteristics | Number of health facilities | % of total |
|---|---|---|
| Public | 45 | 97.8 |
| Faith-based | 1 | 2.2 |
| Health Centre | 36 | 78.3 |
| Zonal Health Centre | 7 | 15.2 |
| Mission/Level 1 Hospital | 3 | 6.5 |
| Rural | 38 | 82.6 |
| Urban | 4 | 8.7 |
| Semi-Urban | 4 | 8.7 |
| Chongwe | 21 | 45.7 |
| Kafue | 15 | 32.6 |
| Luangwa | 10 | 21.7 |
| No | 6 | 13 |
| Yes | 40 | 87 |
| 46 | 100 |
Fig 1Readiness index by district.
The horizontal red line indicates the cut off below which a district was considered as ‘not ready’ to manage NCDs.
Fig 2Readiness index by facilities.
The vertical red line indicates the cut off below which a facility was considered as ‘not ready’ to manage NCDs.
Fig 3Domain-specific index by district.
The red horizontal line indicates the cut off below which a district was considered as ‘not ready’ for that domain to manage NCDs.
Difference in essential medicine availability by rural-urban status.
| Essential medicine availability | Rural (N = 38) | Urban & Semi-Urban (N = 8) | Fisher's exact p-value |
|---|---|---|---|
| n (%) | n (%) | ||
| Beta Blockers | 11 (29) | 2 (25) | 1.000 |
| Antibiotics | 36 (95) | 8 (100) | 1.000 |
| Diuretics | 21 (55) | 6 (75) | 0.440 |
| ACE Inhibitors | 1 (3) | 2 (25) | 0.074 |
| Steroids | 37 (97) | 7 (88) | 0.321 |
| Oral antihyperglycemics | 17 (45) | 4 (50) | 1.000 |
| Analgesics | 30 (79) | 6 (75) | 1.000 |
| Salbutamol inhaler | 28 (74) | 6 (75) | 1.000 |
| Epileptic drugs | 15 (40) | 3 (38) | 1.000 |
| Calcium channel blockers | 6 (16) | 5 (63) | |
| Adrenaline (injection) | 26 (68) | 7 (88) | 0.409 |
| Aspirin | 25 (66) | 6 (75) | 1.000 |
| Insulin (long acting) | 4 (11) | 4 (50) | |
| Insulin (soluble) | 7 (18) | 3 (38) | 0.344 |
| Statins (lovastatin or simvastatin) | 0 | 0 | |
| Sodium chloride infusion | 33 (87) | 6 (75) | 0.587 |
| Glyceryl trinitrate | 2 (5) | 1 (13) | 0.444 |
| Clotrimoxazole | 35 (92) | 7 (88) | 0.548 |
| Promethazine injection | 34 (89) | 8 (100) | 1.000 |
| Glucose injectable | 31 (82) | 7 (88) | 1.000 |
| Aminophylline | 29 (76) | 6 (75) | 1.000 |